View in browser

Researchers at the UC San Diego, School of Medicine have been granted two new awards from the NIH to develop and clinically evaluate technologies capable of noninvasively examining and quantifying immune cells present in tumors. 

On Thursday, April 11, from 1:00 p.m. to 2:00 p.m., Dr. Luis G. Carvajal-Carmona, Auburn Community Cancer Endowed Chair in Basic Science and Associate Vice Chancellor for the Office of Academic Diversity, will present "Bench to Community Approaches to Advance Cancer Health Equity." 

See the San Diego Padres face off against the Chicago Cubs at Petco Park in downtown San Diego (just a few blocks from the San Diego Convention Center, site of the AACR Annual Meeting 2024). Enjoy an evening of major league baseball and support the AACR’s mission to prevent and cure all cancers. 

The GSITA program enables talented scientists from nine countries—Argentina, Brazil, China, Ethiopia, Ghana, India, Jordan, Malaysia, and South Africa—to present their research at Moores, following their attendance at the AACR Annual Meeting 2024.

Program Schedule:

5:15–5:45 p.m. Poster Presentation—Explore diverse cancer research topics and learn about Moores Shared Resources.

5:45–6:30 p.m. Networking Reception—Connect with visiting scholars and forge new collaborations.

Your input is essential in guiding the future of Moores. You are invited to share your thoughts through the surveys below. Your voice matters and will shape Moores planning efforts. 

1. Closing April 15, 2024: Moores Office of Translational Science and Shared Resource Survey

*Time to complete: 120 seconds*

2. Active Now: UCSD Researchers Wellness Survey

Please reply to the personalized link sent via email

*Third-party data collection to ensure anonymity*

3.Coming Soon: First Moores Climate Survey for CCSG Renewal–Email 

Email (mcc_edi@health.ucsd.edu) for questions 

*Third party data collection to ensure anonymity*

April 11, 2024 | 9:00 a.m.

Leichtag Biomedical Research Building Room 107 

April 17, 2024 | 12:00 p.m.

Comer Commons 

May 1, 2024 | 12:00 p.m.

Comer Commons

May 10, 2024 | 12:00 p.m.

Comer Commons

April 11, 2024 | 4:30 to 7:00 p.m.

SDSU Alumni Center 

Receive expert advice from San Diego State University and UC San Diego faculty members Dr. Leonardo Nogueria, Dr. Teresa Monkkonen, and Dr. Hari Narayan

Designed for the next generation of translational surgeon-scientists, SOAS provides rigorous training in three disciplines: (1) the tumor microenvironment; (2) techniques of biobanking; (3) innovation and entrepreneurship. This unique training program features 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications to participate in SOAS must be submitted by April 15, 2024.

The CT2 Training Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at Moores. CT2 trainees not only execute a research program under the direction of a Moores Member, but also participate in coursework, seminars, and lectures. CT2 graduates are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment. Applications to participate in CT2 must be submitted by April 15, 2024.

This program will fund a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs that target health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer among populations that are underserved (and/or underrepresented). Proposed U54 CHD-MH SPOREs projects may investigate more than one cancer type among underserved populations, which include groups of highly related cancers (e.g., gastrointestinal, neuroendocrine, and head and neck). Proposed projects must (1) be translational, (2) stem from knowledge of human biology, (3) address the interplay of various determinants of health with the biology of the disease, and (4) have the goal of reaching a translational human endpoint within the project period of the grant. 

Deadline: September 26, 2024

Journal of Clinical Oncology

Shailja Shah, MD, MPH (Cancer Control Program), Samir Gupta, MD (Cancer Control Program), and Joshua Demb, PhD (Cancer Control Program)

Gastroenterology

Andy Lowy, MD (Solid Tumor Therapeutics), Lisa Madlensky, PhD 

 (Cancer Control Program), and Scott Lippman, MD (Cancer Control Program)

Blood

Prashant Mali, PhD (Cancer Biology and Signaling)

PI:  Peter Vu, MD

NCT: NCT05783622 

PI: Rana McKay, MD

NCT: NCT05928806

PI: Tyler Seibert, MD, PhD

NCT: NCT05223803

Last week, COE, with the California Colorectal Cancer Coalition, promoted cancer screenings and raised awareness of colorectal cancer at the Jackie Robinson YMCA Health Fair. COE educated over 140 individuals and shared important cancer educational materials. If you would like to join COE at the next Health Fair, then please contact COE at mcccoe@health.ucsd.edu.

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback